drugset / Trial / NCT00383643

Xyrem(Sodium Oxybate) and Ambien(Zolpidem Tartrate) in the Treatment of Chronic Insomnia.

NCT00383643

Phase 2 Completed 48 enrolled Stanford University
RandomizedParallel-groupTriple-blindTreatment

Summary

The primary purpose of the study is to evaluate the long term efficacy of sodium oxybate (Xyrem®) and zolpidem tartrate (Ambien®) in treating chronic insomnia. We will compare the efficacy of sodium oxybate with zolpidem tartrate (Ambien®), and compare the efficacy of each of these two medications with placebos.

Timeline

Start
2006-05
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sodium Oxybate Unknown 2.25 g
Comparator Zolpidem Small molecule 5 mg